Page last updated: 2024-09-04

moxifloxacin and ab103

moxifloxacin has been researched along with ab103 in 1 studies

Compound Research Comparison

Studies (moxifloxacin)	Trials (moxifloxacin)	Recent Studies (post-2010) (moxifloxacin)	Studies (ab103)	Trials (ab103)	Recent Studies (post-2010) (ab103)
3,157	552	1,690	6	3	6

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bosc, R; Chosidow, O; De Prost, N; Hua, C; Hughes, C; Jabre, P; Le Cleach, L; Sbidian, E	1

Reviews

1 review(s) available for moxifloxacin and ab103

Article	Year
Interventions for necrotizing soft tissue infections in adults. The Cochrane database of systematic reviews, 2018, 05-31, Volume: 5 Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; CD28 Antigens; Critical Care; Debridement; Female; Fluoroquinolones; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Moxifloxacin; Randomized Controlled Trials as Topic; Soft Tissue Infections	2018

Article

Year

Interventions for necrotizing soft tissue infections in adults.

The Cochrane database of systematic reviews, 2018, 05-31, Volume: 5

Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; CD28 Antigens; Critical Care; Debridement; Female; Fluoroquinolones; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Moxifloxacin; Randomized Controlled Trials as Topic; Soft Tissue Infections

2018